Please make payable to the "Trustees of Columbia University” and indicate "IMO Dr. Kim's honor may be dropped off to Tessa Bouche in The Neurological Institute of New York, Chairman's Office, Suite 104, or mailed to: Memorial donations to establish an annual lecture in Dr. Hartford Memorial Chapel in the Presbyterian Hospital (PH) building of NewYork-Presbyterian/Columbia University Medical Center on Friday, December 22, 2017, at 3:00 PM. There will be a service in his memory at the Pauline A. He is survived by his parents, Young Han and Jung Soon Kim a sister and her husband, Eunice and Mark Chang a sister, Rebecca Kimura and his 6 nieces: Rachel, Maddie, Isabelle, Sophie, Colette, and Annalise. He was an outstanding teacher, and all who worked with him considered him a true friend and a caring physician. Kim was an expert clinician a favorite of his colleagues, referring physicians, residents, and his patients. He came to Columbia University-New York Presbyterian Hospital in 1994, completed a residency in neurology and, after his training, joined the faculty.ĭr. He attended the University of Rochester, where he attained a BS and subsequently a PhD before attending medical school at the State University of New York Health Science Center in Syracuse. Kim was born in South Korea and came to the United States as a child.
He died suddenly and unexpectedly on December 5, 2017, at the age of 55.ĭr. Aduhelm is an antibody (i.e. Amyloid beta may be an important protein in the progression of Alzheimer’s disease. Peter Kim, MD, PhD was an associate professor of neurology at the Columbia University Medical Center. Aducanumab (Aduhelm) at the University of Florida On June 7, 2021, the FDA approved the medication Aducanumab (Aduhelm) for use in Alzheimer’s disease.